Evidence map›Paper›PMID 29194339›Full record

Trial reportShock (Augusta, Ga.)2018

Risk Factors for the Development of Acute Respiratory Distress Syndrome Following Hemorrhage.

Bryce R H Robinson, Mitchell J Cohen, John B Holcomb, Timothy A Pritts, Dina Gomaa, Erin E Fox, Richard D Branson, Rachael A Callcut, Bryan A Cotton, Martin A Schreiber and 8 more

Abstract readMulticenter StudyRandomized Controlled TrialPragmatic Clinical Trial
In one paragraph

Trial report in Shock (Augusta, Ga.), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 1 pooled it
7.3field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 1 synthesis or guideline pooled it, 60 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Article
  5. Article
  6. Review
  7. Article
  8. Observational
  9. Article
  10. Article
  11. Review
  12. Is chest imaging relevant in diagnosing acute respiratory distress syndrome in polytrauma patients? A population-based cohort study.European journal of trauma and emergency surgery : official publication of the European Trauma Society · 2020
    Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 8 institutions in 1 country.

Bryce R H RobinsonDivision of Trauma and Critical Care, Department of Surgery, School of Medicine, University of Washington, Seattle, Washington.
Mitchell J CohenDepartment of Surgery, Denver Health Medical Center, University of Colorado, Denver, Colorado.
John B HolcombCenter for Translational Injury Research, Division of Acute Care Surgery, Department of Surgery, Medical School, University of Texas Health Science Center at Houston, Houston, Texas.
Timothy A PrittsDivision of Trauma and Critical Care, Department of Surgery, University of Cincinnati, Cincinnati, Ohio.
Dina GomaaDivision of Trauma and Critical Care, Department of Surgery, University of Cincinnati, Cincinnati, Ohio.
Erin E FoxCenter for Translational Injury Research, Division of Acute Care Surgery, Department of Surgery, Medical School, University of Texas Health Science Center at Houston, Houston, Texas.
Richard D BransonDivision of Trauma and Critical Care, Department of Surgery, University of Cincinnati, Cincinnati, Ohio.
Rachael A CallcutDivision of General Surgery, Department of Surgery, School of Medicine, University of California San Francisco, San Francisco, California.
Bryan A CottonCenter for Translational Injury Research, Division of Acute Care Surgery, Department of Surgery, Medical School, University of Texas Health Science Center at Houston, Houston, Texas.
Martin A SchreiberDivision of Trauma, Critical Care and Acute Care Surgery, School of Medicine, Oregon Health and Science University, Portland, Oregon.
Karen J BraselDivision of Trauma, Critical Care and Acute Care Surgery, School of Medicine, Oregon Health and Science University, Portland, Oregon.
Jean-Francois PittetDivision of Critical Care and Perioperative Medicine, Department of Anesthesiology, School of Medicine, University of Alabama at Birmingham, Birmingham, Alabama.
Kenji InabaDivision of Trauma and Critical Care, University of Southern California, Los Angeles, California.
Jeffery D KerbyDivision of Trauma, Burns and Surgical Critical Care, Department of Surgery, School of Medicine, University of Alabama at Birmingham, Birmingham, Alabama.
Thomas M ScaleaR Adams Cowley Shock Trauma Center, Program in Trauma, University of Maryland School of Medicine, Baltimore, Maryland.
Charlie E WadeCenter for Translational Injury Research, Division of Acute Care Surgery, Department of Surgery, Medical School, University of Texas Health Science Center at Houston, Houston, Texas.
Eileen M BulgerDivision of Trauma and Critical Care, Department of Surgery, School of Medicine, University of Washington, Seattle, Washington.
PROPPR Study Group
Division of Chemistry · USThe University of Texas Health Science Center at Houston · USOregon Health & Science University · USUniversity of California, San Francisco · USUniversity of Cincinnati · USUniversity of Colorado Denver · USUniversity of Southern California · USUniversity of Washington · US

Funding

Resuscitation Outcomes Consortium (ROC) Data Coordinating CenterU01HL077863 · NHLBI · UNIVERSITY OF WASHINGTON · PI MAY, SUSANNE · 2004 to 2015
$125.1M
Advancing Outcome Metrics in Trauma Surgery Through Utilization of Big DataK01ES026834 · NIEHS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI CALLCUT, RACHAEL A · 2015 to 2018
$889k
CIHR CRR-120612NHLBI NIH HHS U01 HL077863NIEHS NIH HHS K01 ES026834
6 · The paper itself

Abstract

backgroundThe Pragmatic Randomized Optimal Platelet and Plasma Ratios (PROPPR) study evaluated the effects of plasma and platelets on hemostasis and mortality after hemorrhage. The pulmonary consequences of resuscitation strategies that mimic whole blood, remain unknown.

methodsA secondary analysis of the PROPPR study was performed. Injured patients predicted to receive a massive transfusion were randomized to 1:1:1 versus 1:1:2 plasma-platelet-red blood cell ratios at 12 Level I North American trauma centers. Patients with survival >24 h, an intensive care unit (ICU) stay, and a recorded PaO2/FiO2 (P/F) ratio were included. Acute respiratory distress syndrome (ARDS) was defined as a P/F ratio < 200, with bilateral pulmonary infiltrates, and adjudicated by investigators.

resultsFour hundred fifty-four patients were reviewed (230 received 1:1:1, 224 1:1:2). Age, sex, injury mechanism, and regional abbreviated injury scale (AIS) scores did not differ between cohorts. Tidal volume, positive end-expiratory pressure, and lowest P/F ratio did not differ. No significant differences in ARDS rates (14.8% vs. 18.4%), ventilator-free (24 vs. 24) or ICU-free days (17.5 vs. 18), hospital length of stay (22 days vs. 18 days), or 30-day mortality were found (28% vs. 28%). ARDS was associated with blunt injury (OR 3.61 [1.53-8.81] P < 0.01) and increasing chest AIS (OR 1.40 [1.15-1.71] P < 0.01). Each 500 mL of crystalloid infused during hours 0 to 6 was associated with a 9% increase in the rate of ARDS (OR 1.09 [1.04-1.14] P < 0.01). Blood given at 0 to 6 or 7 to 24 h were not risk factors for lung injury.

conclusionAcute crystalloid exposure, but not blood products, is a potentially modifiable risk factor for the prevention of ARDS following hemorrhage.

Indexed as

Blood Component TransfusionLength of StayRespiratory Distress SyndromeAdultCrystalloid SolutionsDisease-Free SurvivalFemaleHemorrhageHumansMaleMiddle AgedSurvival RateCrystalloid Solutions

Identifiers

PMID29194339
PMCPMC5976504
OpenAlexW2774009472

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.